Buying Opportunities After Excessive Corrections? Focus Shifts to Oversold Biotech Stocks

Although the sharp decline in major KOSDAQ bio stocks has dampened overall investment sentiment in the pharmaceutical and biotech sectors, the securities industry views this as a phase following excessive correction. While short-term risks have increased volatility, many analysts believe the drop was excessive considering the execution of core businesses and new partnership achievements. There is also discussion about the possibility of funds, which had been concentrated in semiconductors, robotics, and automobiles, being redistributed.

In the market, global interest rate trends and the recovery of overseas biotech indices are being closely watched as key leading indicators. Experts advise that a selective approach is effective, focusing on companies that are anticipating technology transfer or clinical events following annual global pharma and biotech conferences. For stocks that have recently plummeted and companies that experienced high volatility shortly after listing, there is a growing view that these represent mid- to long-term opportunities.

[Industry leader HighStockLoan direct link: https://www.hisl.co.kr/5113]

Meanwhile, interest in stock loans continues to rise. Investors seeking to seize rare investment opportunities are turning their attention to stock loans, which allow them to leverage more capital for stock purchases.

Another advantage of stock loans is that even if investors face a forced sale crisis due to a sharp stock price drop while using unsettled or margin accounts, they can simply switch products without additional collateral or selling their holdings and wait for a rebound.

◆ HighStockLoan, offering the industry's lowest annual interest rate in the 4% range for additional investment funds and refinancing unsettled/margin balances!

HighStockLoan has launched a securities-linked credit product with the industry's lowest annual interest rate in the 4% range, allowing anyone to experience stock loans without burden. It can be used for stock purchases as well as for refinancing unsettled or margin balances at securities firms, and up to four times the investor's own capital can be utilized regardless of credit rating.

Additionally, for investors who have had difficulty using stock loans due to DSR (Debt Service Ratio) limits, there are products available that can be used regardless of DSR. Investors using the alternative trading system (NXT) can also benefit from these offerings.

Investors interested in learning more about HighStockLoan's various customized products can contact the customer service center (☎1566-5113) at any time, 24 hours a day, to receive convenient expert consultation regardless of loan approval status.

○ Launch of industry’s lowest annual interest rate products in the 4% range

○ DSR-agnostic products available

○ No. 1 market share for 22 consecutive years, Korea First Brand Award for 17 consecutive years

○ Real-time repayment of unsettled/margin balances at securities firms

○ Alternative trading system (NXT) transactions supported

○ Reliable consultation quality guarantee system

* HighStockLoan Consultation Center: 1566-5113

Direct link: https://www.hisl.co.kr/5113

HURIM ROBOT, SAMSUNG ELECTRONICS CO,.LTD, SK hynix Inc., HYUNDAI MOTOR CO, NAVER Corporation

※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.

This content was produced with the assistance of AI translation services.